Home > Drug Search >
  • company_query: Adprotech
  •   > 
Drug Filter
Category:
chemistry (9) biology (26)
Status:
Approved (7) BLA Filing (1) Phase Ⅲ (6) Phase Ⅱ (11) Phase Ⅰ (10)
Clinical Stage:
Pending (3) Active (22) Discontinued (3)
Bio-Type:
Coagulation factor (1) CAR T cell therapy (1) Vaccine (6) Blood extraction (1) Animal extract (1) Recombinant cytokines (2) Bispecific antibody (2) Whole antibody (6) ADC (1) Fusion protein (1)
Indication:
Non-alcoholic steatohepatitis (1) Acute myeloid Leukemia (AML) (2) Allergic conjunctivitis (1) Alzheimer's disease (AD) (3) Anemia (1) Anxiety (2) Breast cancer (1) Rectal cancer (1) Erectile dysfunction (ED) (1) Eye disorders (1) Gastric cancer (1) Alcoholic hepatitis (1) HIV infection (1) Multiple myeloma (MM) (1) Myelodysplastic syndrome (MDS) (1) Non small cell lung cancer (NSCLC) (1) Non-Hodgkin’s lymphoma (NHL) (1) Pancreatic cancer (2) Parkinson's disease (PD) (1) Rheumatoid arthritis (RA) (2) Schizophrenia (1) Solid tumours (2) Nasopharyngeal cancer (1) Hodgkin lymphoma (1) Colorectal cancer (2) Venezuelan equine encephalitis virus infection (1) Primary humoral immunodeficiency (1) Anthrax (1) Age-related macular degeneration (AMD) (1) Autistic disorder (1) Malaria (1) Hemophilia B (1) Neutropenia (1) Kaposi's sarcoma (1) Viral hemorrhagic fever (1) Progressive supranuclear palsy (1) Plaque psoriasis (2) Dengue fever (2) Cardiac reperfusion injury (1) Coronary restenosis (1) hematological malignancies (1) Immune thrombocytopenic purpura (1)
Country:
US (2) EU (1) GB (1)
Aprv. Year:
1999 (1) 2001 (1) 2009 (1) 2010 (1) 2013 (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top